Listed by the USPTO as GIULIANI, THOMAS ANTHONY
Tech Center 3700 • Art Units: 3739 3794
This examiner grants 76% of resolved cases
GIULIANI, THOMAS ANTHONY is assigned to Technology Center 3700 and Art Unit 3739. Across 763 resolved cases, the allowance rate is 76.5%, and the median time to allowance is 1219 days. The interview lift is 37.3%, indicating a substantial positive association between interviews and allowance outcomes.
The principal companies are Boston Scientific Corporation, Cilag GmbH International, and Maquet Cardiovascular LLC. The leading firms are Nelson Mullins Riley & Scarborough LLP, SCHWEGMAN LUNDBERG & WOESSNER, P.A., and Blank Rome LLP. Practitioners should consider interviews an important part of a coordinated medical-device prosecution strategy. The allowance rate provides a favorable outcome signal, while the median timeline requires planning for extended examination. The company affiliations indicate cardiovascular and surgical-device matters where operational detail may support claim distinction.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19030846 | SYSTEMS, DEVICES, AND METHODS FOR ABLATION OF ENDOCARDIAL TISSUE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 19029543 | METHODS AND DEVICES FOR ACCESS ACROSS ADJACENT TISSUE LAYERS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18809711 | VAPOR ABLATION SYSTEMS AND METHODS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18536539 | ABLATION SYSTEMS AND METHODS OF USE | Non-Final OA | INTUITIVE SURGICAL OPERATIONS, INC. |
| 18999349 | CAPACITIVE COUPLED RETURN PATH PAD WITH SEPARABLE ARRAY ELEMENTS | Non-Final OA | Cilag GmbH International |
| 18975122 | SUPPLYING ELECTRICAL ENERGY TO ELECTROSURGICAL INSTRUMENTS | Non-Final OA | CILAG GMBH INTERNATIONAL |
| 18590475 | SINGLE SHOT ELECTRICAL ISOLATION OF ELECTROSURGICAL INSTRUMENT END EFFECTORS | Final Rejection | CILAG GMBH INTERNATIONAL |
| 18010553 | DEVICE AND METHOD FOR DELIVERING ELECTROPORATION THERAPY | Non-Final OA | St. Jude Medical, Cardiology Division, Inc. |
| 18062692 | SYSTEMS AND METHODS FOR SEPARATING NATIVE HEART VALVE LEAFLETS ATTACHED TOGETHER BY A FIXATION DEVICE | Final Rejection | EVALVE, INC. |
| 18906402 | DEFORMATION BASED PRESSURE SENSING | Non-Final OA | BIOSENSE WEBSTER (ISRAEL) LTD. |
| 18778271 | Treatment tool | Final Rejection | OLYMPUS MEDICAL SYSTEMS CORP. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy76.5% of resolved applications examined by Thomas Anthony Giuliani were allowed (763 resolved cases), compared with 0.0% across Art Unit 3739 over the last five years.
This examiner's interview lift is +37.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Thomas Anthony Giuliani took 1,219 days on average from filing to allowance.
Thomas Anthony Giuliani examines applications in Art Unit 3739 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
